AmnioDefend FT Matrix consists of all three layers of the placental membranes including amnion, intermediate layer, and chorion.
INTENDED USES: AmnioDefend FT Matrix is composed of extracellular matrix proteins and serves as a natural, biological barrier or wound cover. The typical population receiving treatment ncludes individuals who require a barrier or wound cover for acute and chronic wounds.
CLAIMED BENEFITS: AmnioDefend FT Matrix is a minimally manipulated human placental membrane product derived from donated placental tissues that retain the structural and functional characteristics of the tissues. The final product is dehydrated, packaged in different-size sheets, and terminally sterilized by irradiation.
Application of Skin Substitutes (also known as Cellular and/or Tissue Based Products) to certain wounds may help these wounds heal faster than conventional dressings and conservative treatments. Usually skin substitutes are used if conventional treatment has been tried for at least 30 days and the wound has not healed as quickly as expected. Human skin allografts are a type of skin substitute. They are made of skin donated by human donors that have had intact cells removed or treated to avoid immunologic rejection (a process in which the body of the person receiving the skin substitute kills the cells of the skin substitute).
For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.
An invitation to view this topic will be emailed to specified recipients.
Sorry, this content is only available to registered members. Please register for FREE account to gain access.
To access this premium feature and more, upgrade to a premium plan today. Or browse to enjoy free content and tools.
WoundReference is a clinical decision support platform for experienced and new wound care clinicians at the point-of-care